These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7905218)

  • 21. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.
    Verdejo A; Toribio I; Orozco C; Puente KL; Pérez-García M
    Drug Alcohol Depend; 2005 Jun; 78(3):283-8. PubMed ID: 15893159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What's in a number?
    Weisberg D
    Hastings Cent Rep; 2012; 42(3):10-1. PubMed ID: 22627715
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.
    Al-Sardar H
    Br J Hosp Med (Lond); 2007 Apr; 68(4):221; author reply 221. PubMed ID: 17469230
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased assessment and monitoring needed for patients receiving methadone.
    Merlo LJ; Gold MS
    Am J Med; 2008 May; 121(5):e23; author repply e25. PubMed ID: 18456018
    [No Abstract]   [Full Text] [Related]  

  • 26. Methadone vs naltrexone.
    Blansfield HN
    Conn Med; 1997 Jan; 61(1):53-4. PubMed ID: 9040159
    [No Abstract]   [Full Text] [Related]  

  • 27. Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
    Nielsen S; Dietze P; Cantwell K; Lee N; Taylor D
    J Subst Abuse Treat; 2008 Dec; 35(4):457-61. PubMed ID: 18295435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone and excessive sweating.
    Al-Adwani A; Basu N
    Addiction; 2004 Feb; 99(2):259. PubMed ID: 14756718
    [No Abstract]   [Full Text] [Related]  

  • 30. [Life-threatening, recurrent arrhythmia in patients on high-dose methadone treatment: torsade de pointes].
    Al-Shakarshi JS; Bent-Hansen L; Jensen GB
    Ugeskr Laeger; 2004 Aug; 166(36):3104-5. PubMed ID: 15387312
    [No Abstract]   [Full Text] [Related]  

  • 31. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 33. Methadone and caries.
    Meaney PJ
    Aust Dent J; 1997 Apr; 42(2):138. PubMed ID: 9153846
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dogmatism on methadone].
    Waal H
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3996. PubMed ID: 9830350
    [No Abstract]   [Full Text] [Related]  

  • 35. An update on the role of opioids in the management of chronic pain of nonmalignant origin.
    Højsted J; Sjøgren P
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):451-5. PubMed ID: 17873598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological correlates of opioid dependence and withdrawal.
    Lyvers M; Yakimoff M
    Addict Behav; 2003 Apr; 28(3):605-11. PubMed ID: 12628632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interactions with methadone and buprenorphine].
    Bakke E; Bachs L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2364-6. PubMed ID: 19935937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reluctance to order opioids in elders.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Sep; 97(9):20, 23. PubMed ID: 9311334
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.